Literature DB >> 26894118

Isolated CNS Blast Crises in Chronic Myeloid Leukaemia Presenting as Hypertrophic Pachymeningitis and Bilateral Optic Neuritis: A Case Report.

Ankur Jain1, Naresh Gupta2.   

Abstract

Extramedullary blast crises of Chronic Myeloid Leukaemia (CML) involving CNS is rare and usually accompanies systemic relapse. Isolated CNS blast relapse is an extremely uncommon event. A 35-year-old male was diagnosed with chronic phase (CP) CML two years back at our hospital and was started on imatinib 400 mg daily. Patient achieved haematological and cytogenetic remission at three and 12 months respectively but was non-compliant with medications thereafter. He presented to our emergency with headache and bilateral visual loss. CNS examination revealed neck rigidity and fundoscopy revealed disc edema with retinal vein dilatation and haemorrhages. Cerebrospinal fluid (CSF) analysis revealed lymphocytic pleocytosis and a positive cytospin for myeloid blasts. MRI brain suggested pachymeningeal enhancement involving falx cerebri and tentorium along with bilateral optic nerve thickening. Patient maintained cytogenetic remission at current presentation. A diagnosis of isolated CNS blast crises with pachymeningitis and bilateral optic nerve involvement was made and two doses of intrathecal chemotherapy were administered. However, patient died due to a rapidly downhill course. A previously unreported finding of pachymeningitis with bilateral optic neuritis has been highlighted in this case, along with a brief review of this rare condition.

Entities:  

Keywords:  Allogenic stem cell transplantation; Chemoradiotherapy; Extramedullary blast crises; Imatinib

Year:  2016        PMID: 26894118      PMCID: PMC4740646          DOI: 10.7860/JCDR/2016/15813.7045

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  22 in total

1.  Isolated central nervous system relapse in patients with chronic myeloid leukemia on imatinib mesylate.

Authors:  Nathalie A Johnson; Raouf Fetni; Stephen N Caplan
Journal:  Leuk Lymphoma       Date:  2005-04

2.  Isolated central nervous system lymphoid blast crisis in chronic myeloid leukaemia in major molecular remission.

Authors:  A Barlow; M Robertson; A Doig; W Stewart; M W Drummond
Journal:  Br J Haematol       Date:  2008-05-15       Impact factor: 6.998

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-1998. A 50-year-old woman with increasing headache and a left abducent-nerve palsy.

Authors: 
Journal:  N Engl J Med       Date:  1998-01-15       Impact factor: 91.245

4.  Visual loss as initial presentation of chronic myelogenous leukemia.

Authors:  Blanka Doko Mandić; Vlatka Potocnjak; Goran Bencić; Zdravko Mandić; Ante Pentz; Tomislav Franjo Hajnzić
Journal:  Coll Antropol       Date:  2005

5.  Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy.

Authors:  Michael E Rytting; William G Wierda
Journal:  Leuk Lymphoma       Date:  2004-08

Review 6.  Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate.

Authors:  Y Isobe; K Sugimoto; A Masuda; Y Hamano; K Oshimi
Journal:  Intern Med J       Date:  2009-06       Impact factor: 2.048

7.  Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.

Authors:  Heike Pfeifer; Barbara Wassmann; Wolf-Karsten Hofmann; Martina Komor; Urban Scheuring; Patrick Brück; Anja Binckebanck; Eberhard Schleyer; Nicola Gökbuget; Thomas Wolff; Michael Lübbert; Lothar Leimer; Harald Gschaidmeier; Dieter Hoelzer; Oliver G Ottmann
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

8.  Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Authors:  Mary Fuchs; Mike Reinhöfer; Andreas Ragoschke-Schumm; Herbert G Sayer; Klas Böer; Otto W Witte; Andreas Hochhaus; Hubertus Axer
Journal:  BMC Blood Disord       Date:  2012-08-07

9.  Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report.

Authors:  Abdullah Altintas; Timucin Cil; Ilhan Kilinc; Muhammet Ali Kaplan; Orhan Ayyildiz
Journal:  J Neurooncol       Date:  2007-02-23       Impact factor: 4.506

10.  Isolated central nervous system relapse in chronic myeloid leukemia.

Authors:  Juliana Gomez; Victor Duenas
Journal:  Case Rep Med       Date:  2015-03-23
View more
  6 in total

Review 1.  Chronic myelogenous leukemia presenting with central nervous system infiltration, successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation.

Authors:  Akira Chiba; Takashi Toya; Hideaki Mizuno; Junji Tokushige; Fumihiko Nakamura; Kumi Nakazaki; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2018-08-04       Impact factor: 2.490

2.  Another Emergent Cause of Headache.

Authors:  Scott R Wambolt; Juan Garza
Journal:  Cureus       Date:  2018-05-14

3.  Myodesopsia is a symptom of central nervous system blast crisis in chronic myeloid leukemia.

Authors:  Kazuyoshi Ishii; Aya Nakaya; Shinya Fujita; Atsushi Satake; Yoshiko Azuma; Yukie Tsubokura; Ryo Saito; Akiko Konishi; Masaaki Hotta; Hideaki Yoshimura; Tomoki Ito; Shosaku Nomura
Journal:  Leuk Res Rep       Date:  2019-03-05

4.  A Rare Monocytic Crisis of Chronic Myelogenous Leukemia Presenting with Unusual Extramedullary Manifestations and an Atypical (14;22)(q24;q11.2) Translocation in the Bone Marrow.

Authors:  Morihiro Inoue; Masao Hagihara; Tomoyuki Uchida; Jian Hua; Takeshi Nakajima; Shogo Tajima; Yasunori Ota
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

5.  Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling.

Authors:  Ka-Young Ryu; Hyun-Ju Lee; Hanwoong Woo; Ri-Jin Kang; Kyung-Min Han; HyunHee Park; Sang Min Lee; Ju-Young Lee; Yoo Joo Jeong; Hyun-Wook Nam; Youngpyo Nam; Hyang-Sook Hoe
Journal:  J Neuroinflammation       Date:  2019-10-26       Impact factor: 8.322

6.  Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis.

Authors:  Ahmed A Bin Salman; Abdul Rehman Zia Zaidi; Syed Yasir Altaf; Nawal F AlShehry; Imran K Tailor; Ibraheem H Motabi; Syed Ziauddin A Zaidi
Journal:  Am J Case Rep       Date:  2020-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.